Viral vectors constitute valuable tools in our gene transfer arsenal. The utility of viral vectors is derived mainly from their unsurpassed ability to deliver genes from the plasma membrane to the nucleus. In vivo experience using experimental animals has confirmed the fact that adeno-associated virus (AAV) vectors yield effective and persistent gene transfer with promise for the treatment of chronic genetic diseases such as cystic fibrosis. To optimize clinical use of gene transfer vectors, variables affecting the dynamics of gene transfer vectors must be characterized and understood. Recent evidence has pointed to intracellular trafficking of AAV vectors as a variable in AAV-mediated gene transfer to airway epithelium. The central hypothesis of this proposal is that the lung tropism of select AAV serotypes is derived, in part, from comparatively efficient intracellular trafficking of the genome to the nucleus in differentiated airway epithelial cells. Cells contain numerous barriers to viral infection including the plasma membrane, a viscous cytosol, and the nuclear envelope. Capitalizing on the experience developed in this laboratory in studies of viral interaction with these intracellutar barriers, we propose to pursue three avenues relevant to the intracellular AAV infection pathway: (1) to conduct a comparative analysis of the ability of different AAV serotypes (including lung-tropic serotypes) to traffic through airway epithelial cells to the nucleus, (2) to determine the extent to which intracellular trafficking of AAV serotypes results from an affinity of the AAV capsid for the microtubule cytoskeleton mediated by the cytoplasmic dynein motor complex, and (3) to evaluate whether proteosomal degradation of the AAV capsid correlates with intracellular trafficking of AAV to the microtubute-organizing center (MTOC). Furthering our knowledge of the mechanism of AAV infection will provide valuable insight that can be used for strategic development ofgene transfer vectors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051746-15
Application #
7649484
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
15
Fiscal Year
2008
Total Cost
$388,705
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Ryan, Dorothy M; Vincent, Thomas L; Salit, Jacqueline et al. (2014) Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 9:e88051
Dvorak, Anna; Tilley, Ann E; Shaykhiev, Renat et al. (2011) Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol 44:465-73
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Limberis, Maria P; Bell, Christie L; Heath, Jack et al. (2010) Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18:143-50
Song, Yuhu; Lou, Howard H; Boyer, Julie L et al. (2009) Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 20:267-81
Vandenberghe, L H; Breous, E; Nam, H-J et al. (2009) Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther 16:1416-28
Fein, David E; Limberis, Maria P; Maloney, Sean F et al. (2009) Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung. Mol Ther 17:2078-87
Limberis, Maria P; Vandenberghe, Luk H; Zhang, Liqun et al. (2009) Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 17:294-301
Tertilt, Christine; Joh, Ju; Krause, Anja et al. (2009) Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 77:3044-55
Limberis, M P; Bell, C L; Wilson, J M (2009) Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 16:441-7

Showing the most recent 10 out of 85 publications